Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

Abstract
COVID-19, the disease caused by SARS-CoV-2 (1), was declared a pandemic by the World Health Organization (WHO) in March 2020 (2). While awaiting a vaccine, several antivirals are being used to manage the disease with limited success (3, 4). To expand this arsenal, we screened 4 compound libraries: a United States Food and Drug Administration (FDA) approved drug library, an angiotensin converting enzyme-2 (ACE2) targeted compound library, a flavonoid compound library as well as a natural product library. Of the 121 compounds identified with activity against SARS-CoV-2, 7 were shortlisted for validation. We show for the first time that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2. This finding paves the way for consideration of host-directed therapies for ring prophylaxis of contacts of SARS-CoV-2 patients.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (9591)
- Bioengineering (7090)
- Bioinformatics (24857)
- Biophysics (12600)
- Cancer Biology (9956)
- Cell Biology (14349)
- Clinical Trials (138)
- Developmental Biology (7948)
- Ecology (12105)
- Epidemiology (2067)
- Evolutionary Biology (15988)
- Genetics (10925)
- Genomics (14738)
- Immunology (9869)
- Microbiology (23660)
- Molecular Biology (9484)
- Neuroscience (50860)
- Paleontology (369)
- Pathology (1539)
- Pharmacology and Toxicology (2682)
- Physiology (4013)
- Plant Biology (8657)
- Synthetic Biology (2394)
- Systems Biology (6433)
- Zoology (1346)